Pozen (POZN)
News
| May 24 | Roth Capital Starts POZEN Inc. (POZN) at Buy Street Insider |
| May 22 | POZEN to Present at the Jefferies 2012 Global Healthcare Conference Business Wire |
| May 20 | 6 Healthcare Stocks Undervalued By Earnings Growth, The Graham Number |
| May 19 | PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg) Business Wire |
| May 18 | $POZN Now you get your chance to cover, shorts, but it isn't related singularly to POZN, it is across the biotech board. by Glopolon |
| May 15 | $POZN Reacting Nicely from lone 5000 share sale in after hours the other day. Whoever dumped could've sold today at 7.15$ instead of 6.51 by Glopolon |
| May 14 | @peterumble http://stks.co/3oy4 One person sells 5,000 shares, on what news? $POZN by Glopolon |
| May 14 | $POZN haha a buck drop of 10% in AH, headed to ZERO? The debacle starts here, shorts relish this stock $$ by peterumble |
| May 14 | Pozen Shares On The Rebound Since European Migraine Licensing Deal |
| May 10 | @JNapodano $POZN, 8K http://stks.co/3mIx Good chart a la $BDSI, except for the drop prior to press conference. Brazil approval also brewing by Glopolon |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Drug Manufacturers - Other
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pozen is up 34.17% over the last year vs S&P 500 Total Return up 0.88%, MAP Pharmaceuticals down 30.72%, and ISTA Pharmaceuticals down 2.15%.
- POZN Total Returns
- ^SPXTR Total Returns
- MAPP Total Returns
- ISTA Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these POZN related companies
Pro Strategies Featuring POZN
Did Pozen make it into our Pro Portfolio Strategies?
POZN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other POZN Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| POZN | 6.91 | -0.11 | -1.57% | 210.46M |
| POWR | 4.14 | -0.16 | -3.72% | 81.31M |
| POWL | 36.78 | +0.01 | +0.03% | 432.05M |
| POWI | 40.76 | +0.13 | +0.32% | 1.149B |
| POT | 39.53 | +0.11 | +0.28% | 33.85B |
| POR | 25.15 | +0.09 | +0.36% | 1.889B |
| PJF | 25.55 | +0.02 | +0.08% | |
| PJC | 21.90 | +0.28 | +1.30% | 411.43M |
| PIZ | 17.00 | +0.05 | +0.29% | |
| PIV | 14.73 | -0.18 | -1.20% |
